RE: New report.. Bail...I just received this email from E Research.
Some things i find very peculiar from our "PAID" analyst.
Firstly his target price has often been 1/3rd that of the independent analysts with meagre discussion of upside. I could never figure out quite why the fellow seemed so dour about having to handle the Bioniche account.
More interestingly though is the terminology he uses in his most recent release...."Econiche allegedly lowers e coli in cattle by up to 99%". Allegedly...Huh, that would imply that this is somehow an unsubstantiated, but not wholly unreasonable claim by Bioniche and certainly leaving doubt in the mind of the reader.
It is my understanding, and that of most here, that this claim has been entirely substantiated by both Bioniche and external studies as well as peer reviewed journals, all which would have encompassed the submission to the CFIA. Interesting use of a very powerful, if taken out of context, term.
He also suggests that governments may be reluctant to endorse Econiche " due to the costly nature of the vaccine" ...Again, hmm, the costly nature of the vaccine. Relative to what, tap water or a massive e coli outbreak with crippling lawsuits as we will surely see in the coming days.
I have always struggled with the concept of a "paid" analyst but more so when the tone of the coverage runs somewhat contrary to the established (allegedly of course) facts on hand and the climate within which they are being discussed.